{"log_id": 8603296743344838104, "direction": 0, "words_result_num": 26, "words_result": [{"probability": {"variance": 5.7e-05, "average": 0.996171, "min": 0.958283}, "location": {"width": 824, "top": 246, "height": 31, "left": 246}, "words": "本品剂量达到120mg/kg/天(雌性)和180mg/kg/天(雄性)(分别为预期人体临"}, {"probability": {"variance": 7e-06, "average": 0.998469, "min": 0.988177}, "location": {"width": 837, "top": 293, "height": 33, "left": 204}, "words": "床暴露量的8倍和3倍)对雌性或雄性大鼠的性腺功能、交配和生殖能力均无影响"}, {"probability": {"variance": 4e-06, "average": 0.998572, "min": 0.990114}, "location": {"width": 871, "top": 341, "height": 31, "left": 204}, "words": "雌性大鼠在繁殖期间直到妊娠前6天经口给予拉帕替尼,观察到120mg/kg/d剂量组活"}, {"probability": {"variance": 2e-05, "average": 0.998401, "min": 0.970907}, "location": {"width": 875, "top": 386, "height": 31, "left": 205}, "words": "胚胎数减少,≥60mg/kg/d剂量组鼠胚胎体重降低(分别为预期人体临床暴露量的6.4"}, {"probability": {"variance": 4.3e-05, "average": 0.996379, "min": 0.96922}, "location": {"width": 869, "top": 434, "height": 29, "left": 206}, "words": "倍和3.3倍)。妊娠大鼠和家兔经口给予30mg/kg/天,60mg/kg/天和120mg/kg/天拉"}, {"probability": {"variance": 3e-05, "average": 0.997825, "min": 0.973077}, "location": {"width": 868, "top": 478, "height": 31, "left": 204}, "words": "帕替尼,未显示致畸作用,但是大鼠60mg/kg/天的剂量组(为预期人体临床暴露量的"}, {"probability": {"variance": 4e-06, "average": 0.998774, "min": 0.991734}, "location": {"width": 832, "top": 524, "height": 30, "left": 203}, "words": "4倍)可出现轻微发育异常(左侧脐动脉,颈肋综合症及早熟性骨化)。在家兔组"}, {"probability": {"variance": 8.9e-05, "average": 0.995443, "min": 0.951642}, "location": {"width": 853, "top": 570, "height": 29, "left": 208}, "words": "6mg/kg/天和120mg/kg/天(分别为预期人体临床暴露量的8%和23%)出现母体毒"}, {"probability": {"variance": 2.9e-05, "average": 0.997777, "min": 0.973294}, "location": {"width": 873, "top": 616, "height": 30, "left": 204}, "words": "性,120mg/kg/天组出现流产。母体毒性常导致胎儿体重下降,轻微的骨骼变化。在大"}, {"probability": {"variance": 0.004152, "average": 0.984904, "min": 0.623983}, "location": {"width": 865, "top": 661, "height": 31, "left": 207}, "words": "鼠产前和产后发育研究中显示,在60mg/kg/天或更高剂量组(为预期人体临床暴露量"}, {"probability": {"variance": 0.000107, "average": 0.995882, "min": 0.952196}, "location": {"width": 855, "top": 704, "height": 33, "left": 206}, "words": "的5倍),从出生到产后21天新生大鼠的存活率下降,最大安全剂量是20mg/kg/天"}, {"probability": {"variance": 0, "average": 0.999755, "min": 0.999578}, "location": {"width": 74, "top": 777, "height": 25, "left": 205}, "words": "致癌性"}, {"probability": {"variance": 2e-06, "average": 0.999196, "min": 0.991439}, "location": {"width": 837, "top": 838, "height": 29, "left": 247}, "words": "在口服本品的致癌性试验中,最高剂量组的动物出现了严重的皮肤损害。该组动物"}, {"probability": {"variance": 1e-05, "average": 0.998858, "min": 0.981911}, "location": {"width": 847, "top": 884, "height": 29, "left": 206}, "words": "中小鼠和雄性大鼠的药物暴露量最高至人用剂量(每天一次1250mg拉帕替尼)的2"}, {"probability": {"variance": 4.5e-05, "average": 0.997836, "min": 0.959494}, "location": {"width": 873, "top": 929, "height": 32, "left": 204}, "words": "倍,而雌兔的药物暴露量最高至上述人用剂量的15倍。在小鼠试验中并未观察到致癌"}, {"probability": {"variance": 0.017708, "average": 0.964208, "min": 0.368369}, "location": {"width": 864, "top": 965, "height": 58, "left": 206}, "words": "作用。在大鼠试验中,部分动物出现良性肠系淋巴结血管瘤的几照M"}, {"probability": {"variance": 0.043018, "average": 0.736589, "min": 0.391363}, "location": {"width": 233, "top": 973, "height": 97, "left": 867}, "words": "华润动"}, {"probability": {"variance": 0.003939, "average": 0.969787, "min": 0.711634}, "location": {"width": 854, "top": 1015, "height": 80, "left": 205}, "words": "在雌兔实验中,暴露量为人用剂量(每天一次1250mg拉帕替尼7医药有限公司"}, {"probability": {"variance": 5e-06, "average": 0.998482, "min": 0.990407}, "location": {"width": 421, "top": 1067, "height": 29, "left": 206}, "words": "物出现肾梗塞和乳头坏死几率升高的现象"}, {"probability": {"variance": 0.035049, "average": 0.626451, "min": 0.439237}, "location": {"width": 125, "top": 1083, "height": 42, "left": 950}, "words": "米"}, {"probability": {"variance": 1e-06, "average": 0.998844, "min": 0.99638}, "location": {"width": 174, "top": 1170, "height": 32, "left": 215}, "words": "【药代动力学】"}, {"probability": {"variance": 0, "average": 0.999506, "min": 0.999125}, "location": {"width": 50, "top": 1243, "height": 26, "left": 206}, "words": "吸收"}, {"probability": {"variance": 0.00558, "average": 0.985974, "min": 0.520963}, "location": {"width": 825, "top": 1305, "height": 30, "left": 248}, "words": "本品口服给药吸收不完全,且变异较高(AUC的变异系数大约是50%—100%)。经"}, {"probability": {"variance": 0.001094, "average": 0.991204, "min": 0.78769}, "location": {"width": 877, "top": 1352, "height": 28, "left": 206}, "words": "过平均0.25小时(范围0~1.5小时)的迟滞期后可测得血清药物浓度。给药大约4小"}, {"probability": {"variance": 0.000135, "average": 0.99565, "min": 0.935027}, "location": {"width": 838, "top": 1397, "height": 29, "left": 206}, "words": "时后达到血浆峰浓度(C)。连续给药6-7天可达到稳态,提示有效半衰期为24小"}, {"probability": {"variance": 0, "average": 0.99834, "min": 0.99834}, "location": {"width": 23, "top": 1447, "height": 23, "left": 207}, "words": "时"}], "language": 3}